XETRA - Delayed Quote EUR

Amgen Inc. (AMG.DE)

256.10

-0.05

(-0.02%)

At close: January 10 at 5:35:53 PM GMT+1

Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.

Biotech stocks are poised for an exciting 2025 as experts watch for new weight-loss drugs, AI's impact and Trump's second presidency.

Investor's Business Daily 2 days ago

AMGN

LLY

PFE
Viking Therapeutics Starts Mid-Stage Study on Oral Weight-Loss Drug

The initiation of the phase 2 study is based on early-stage data, which show that patients who received VKTX's obesity pill lost up to 8.2% in body weight after 28 days.

Zacks 2 days ago

VKTX

AMGN
AMGEN TO PRESENT AT 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Amgen (NASDAQ:AMGN) will present at the 2025 J.P. Morgan Healthcare Conference at 3:00 p.m. PT on Monday, January 13, 2025. Robert A. Bradway, chairman and chief executive officer at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

PR Newswire 3 days ago

AMGN
Amgen (AMGN) Advances While Market Declines: Some Information for Investors

Amgen (AMGN) closed at $262.05 in the latest trading session, marking a +1.34% move from the prior day.

Zacks 4 days ago

AMGN
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Zacks 4 days ago

AMGN

NVS
The Zacks Analyst Blog Highlights Microsoft, Exxon Mobil, Amgen, PrimeEnergy Resources and FONAR

Microsoft, Exxon Mobil, Amgen, PrimeEnergy Resources and FONAR are part of the Zacks top Analyst Blog.

Zacks 4 days ago

PNRG

AMGN

MSFT
Amgen (AMGN) Stock Sinks As Market Gains: Here's Why

Amgen (AMGN) concluded the recent trading session at $258.59, signifying a -1.01% move from its prior day's close.

Zacks 5 days ago

AMGN
Top Analyst Reports for Microsoft, Exxon Mobil & Amgen

Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Exxon Mobil Corporation (XOM) and Amgen Inc. (AMGN), as well as two micro-cap stocks PrimeEnergy Resources Corporation (PNRG) and FONAR Corporation (FONR).

Zacks 5 days ago

AMGN

XOM

MSFT
Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report?

Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks 5 days ago

AMGN
Amgen (NASDAQ:AMGN) Is Paying Out A Larger Dividend Than Last Year

Amgen Inc.'s ( NASDAQ:AMGN ) dividend will be increasing from last year's payment of the same period to $2.38 on 7th of...

Simply Wall St. 5 days ago

AMGN
Amgen’s Imdylltra wins conditional MHRA licence for lung cancer

Amgen’s bispecific T-cell engager (BiTE) led to an ORR of 41% in patients with extensive-stage small cell lung cancer.

Pharmaceutical Technology 5 days ago

AMGN

GLDAF
Prediction: These 3 Healthcare Stocks Will Soar in 2025

Here's why they chose Amgen (NASDAQ: AMGN), Eli Lilly (NYSE: LLY), and Summit Therapeutics (NASDAQ: SMMT). David Jagielski (Amgen): Shares of Amgen started crashing in late November following the release of data from a phase 2 clinical trial for its weight loss candidate, MariTide.

Motley Fool 7 days ago

LLY

SMMT

AMGN
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It

Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks 8 days ago

AMGN
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?

The Dow Jones Industrial Average contains 30 handpicked companies that are, or at least once were, leaders in their respective industries. Right now the three highest yielding Dow stocks are Verizon Communications (NYSE: VZ), Chevron (NYSE: CVX), and Amgen (NASDAQ: AMGN). Verizon is one of the largest telecom companies in the United States.

Motley Fool 8 days ago

CVX

VZ

AMGN
The 5 worst-performing stocks on the Dow Jones Industrial Average in 2024

The Dow's biggest losers include companies in the aerospace, biopharma, and sports apparel sectors.

TheStreet 10 days ago

^DJI

JNJ

BA
GLP-1 questions emerge for 2025

The 2025 outlook for GLP-1s isn't as bullish as it once was, but all hope is not lost.

Yahoo Finance 11 days ago

LLY

AMGN

NONOF
Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights

Amgen (AMGN) closed at $259.30 in the latest trading session, marking a -1.28% move from the prior day.

Zacks 12 days ago

AMGN
Is Amgen Inc. (AMGN) the Best Pharma Dividend Stock to Buy In 2024?

We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against the other pharma dividend stocks. The pharmaceutical industry in 2024 faced a relatively quiet year, with deal volumes similar to 2023 but lower […]

Insider Monkey 12 days ago

AMGN
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks 15 days ago

AMGN
3 Healthcare Stocks to Buy for a 2025 Rebound

The Health Care Select Sector SPDR exchange-traded fund has gained 1.2% in 2024, lagging the S&P 500’s 24% gain. Health insurers are generally best avoided now (United Health might be an exception), but there are other opportunities. Two companies with GLP-1 weight loss drugs that might be buying opportunities now are Amgen and Eli Lilly.

Barrons.com 15 days ago

LLY

AMGN

Performance Overview

Return	AMG.DE	S&P 500
YTD	+1.49%	-1.35%
1-Year	-6.01%	+22.51%
3-Year	+41.60%	+24.59%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Amgen Inc. (AMG.DE)

Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.

Viking Therapeutics Starts Mid-Stage Study on Oral Weight-Loss Drug

AMGEN TO PRESENT AT 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Amgen (AMGN) Advances While Market Declines: Some Information for Investors

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

The Zacks Analyst Blog Highlights Microsoft, Exxon Mobil, Amgen, PrimeEnergy Resources and FONAR

Amgen (AMGN) Stock Sinks As Market Gains: Here's Why

Top Analyst Reports for Microsoft, Exxon Mobil & Amgen

Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report?

Amgen (NASDAQ:AMGN) Is Paying Out A Larger Dividend Than Last Year

Amgen’s Imdylltra wins conditional MHRA licence for lung cancer

Prediction: These 3 Healthcare Stocks Will Soar in 2025

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It

Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?

The 5 worst-performing stocks on the Dow Jones Industrial Average in 2024

GLP-1 questions emerge for 2025

Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights

Is Amgen Inc. (AMGN) the Best Pharma Dividend Stock to Buy In 2024?

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

3 Healthcare Stocks to Buy for a 2025 Rebound

Performance Overview